1. Gut Microbiota is critical for the induction of chemotherapy-induced pain
- Author
-
Shiqian Shen, Grewo Lim, Zerong You, Michael F. McCabe, Samuel Tate, Douglas S. Kwon, Chongzhao Ran, Weihua Ding, Peigen Huang, Kun Hu, Jason T Doheny, Hyangin Kim, Lucy Chen, Jianren Mao, Bo Huang, Zhongcong Xie, and Peter Caravan
- Subjects
0301 basic medicine ,Male ,Organoplatinum Compounds ,medicine.drug_class ,medicine.medical_treatment ,Antibiotics ,Pain ,Antineoplastic Agents ,Biology ,Gut flora ,Article ,Rats, Sprague-Dawley ,03 medical and health sciences ,Mechanical Hyperalgesia ,Mice ,Random Allocation ,0302 clinical medicine ,Chemotherapy induced ,medicine ,Animals ,Cells, Cultured ,Pain Measurement ,Mice, Knockout ,Chemotherapy ,General Neuroscience ,biology.organism_classification ,3. Good health ,Oxaliplatin ,Gastrointestinal Microbiome ,Rats ,Mice, Inbred C57BL ,Haematopoiesis ,030104 developmental biology ,Hyperalgesia ,Immunology ,TLR4 ,Female ,Inflammation Mediators ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Chemotherapy-induced pain is a dose-limiting condition that affects 30% of patients undergoing chemotherapy. We found that the gut microbiota promotes the development of chemotherapy-induced mechanical hyperalgesia. Oxaliplatin-induced mechnical hyperalgesia was reduced in germ-free mice and in those mice pretreated with antibiotics. Restoration of the microbiota of germ-free mice abrogated this protection. These effects appear to be mediated, in part, by TLR4 expressed on hematopoietic cells, including macrophages.
- Published
- 2017